» Articles » PMID: 19501001

A Mutation in the Nlrp3 Gene Causing Inflammasome Hyperactivation Potentiates Th17 Cell-dominant Immune Responses

Overview
Journal Immunity
Publisher Cell Press
Date 2009 Jun 9
PMID 19501001
Citations 171
Authors
Affiliations
Soon will be listed here.
Abstract

Missense mutations of the gene encoding NLRP3 are associated with autoinflammatory disorders characterized with excessive production of interleukin-1beta (IL-1beta). Here we analyzed the immune responses of gene-targeted mice carrying a mutation in the Nlrp3 gene equivalent to the human mutation associated with Muckle-Wells Syndrome. We found that antigen-presenting cells (APCs) from such mice produced massive amounts of IL-1beta upon stimulation with microbial stimuli in the absence of ATP. This was likely due to a diminished inflammasome activation threshold that allowed a response to the small amount of agonist. Moreover, the Nlrp3 gene-targeted mice exhibited skin inflammation characterized by neutrophil infiltration and a Th17 cytokine-dominant response, which originated from hematopoietic cells. The inflammation of Nlrp3 gene-targeted mice resulted from excess IL-1beta production from APCs, which augmented Th17 cell differentiation. These results demonstrate that the NLRP3 mutation leads to inflammasome hyperactivation and consequently Th17 cell-dominant immunopathology in autoinflammation.

Citing Articles

The Role of IL-17 in Systemic Autoinflammatory Diseases: Mechanisms and Therapeutic Perspectives.

Zhang J, Shen M Clin Rev Allergy Immunol. 2025; 68(1):27.

PMID: 40074883 DOI: 10.1007/s12016-025-09042-5.


Adult-Onset Still's Disease (AOSD)-On the Basis of Own Cases.

Wislowska M Biomedicines. 2024; 12(9).

PMID: 39335580 PMC: 11428668. DOI: 10.3390/biomedicines12092067.


Anti-Cytokine Active Immunotherapy Based on Supramolecular Peptides for Alleviating IL-1β-Mediated Inflammation.

Shetty S, Wu Y, Lloyd C, Mehta N, Liu Y, Woodruff M Adv Healthc Mater. 2024; 14(5):e2401444.

PMID: 39113323 PMC: 11802897. DOI: 10.1002/adhm.202401444.


NLRP3, NLRP6, and NLRP12 are inflammasomes with distinct expression patterns.

Wei B, Billman Z, Nozaki K, Goodridge H, Miao E Front Immunol. 2024; 15:1418290.

PMID: 39076995 PMC: 11284034. DOI: 10.3389/fimmu.2024.1418290.


Living with your biome: how the bacterial microbiome impacts ocular surface health and disease.

Lai J, Rigas Y, Kantor N, Cohen N, Tomlinson A, St Leger A Expert Rev Ophthalmol. 2024; 19(2):89-103.

PMID: 38764699 PMC: 11101146. DOI: 10.1080/17469899.2024.2306582.


References
1.
Pelegrin P, Surprenant A . Pannexin-1 couples to maitotoxin- and nigericin-induced interleukin-1beta release through a dye uptake-independent pathway. J Biol Chem. 2006; 282(4):2386-94. DOI: 10.1074/jbc.M610351200. View

2.
Anderson J, Mueller J, Rosengren S, Boyle D, Schaner P, Cannon S . Structural, expression, and evolutionary analysis of mouse CIAS1. Gene. 2004; 338(1):25-34. PMC: 4348074. DOI: 10.1016/j.gene.2004.05.002. View

3.
Neven B, Callebaut I, Prieur A, Feldmann J, Bodemer C, Lepore L . Molecular basis of the spectral expression of CIAS1 mutations associated with phagocytic cell-mediated autoinflammatory disorders CINCA/NOMID, MWS, and FCU. Blood. 2003; 103(7):2809-15. DOI: 10.1182/blood-2003-07-2531. View

4.
Nograles K, Zaba L, Guttman-Yassky E, Fuentes-Duculan J, Suarez-Farinas M, Cardinale I . Th17 cytokines interleukin (IL)-17 and IL-22 modulate distinct inflammatory and keratinocyte-response pathways. Br J Dermatol. 2008; 159(5):1092-102. PMC: 2724264. DOI: 10.1111/j.1365-2133.2008.08769.x. View

5.
Chabaud M, Fossiez F, Taupin J, Miossec P . Enhancing effect of IL-17 on IL-1-induced IL-6 and leukemia inhibitory factor production by rheumatoid arthritis synoviocytes and its regulation by Th2 cytokines. J Immunol. 1998; 161(1):409-14. View